Return to search

Assessing changes in the utilization of rivaroxaban in patients with atherosclerotic cardiovascular disease following the COMPASS RCT

No description available.

1. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-468916

Identifer	oai:union.ndltd.org:UPSALLA1/oai:DiVA.org:uu-468916
Date	January 2022
Creators	Salih, Allan
Publisher	Uppsala universitet, Institutionen för farmaci
Source Sets	DiVA Archive at Upsalla University
Language	English
Detected Language	English
Type	Student thesis, info:eu-repo/semantics/bachelorThesis, text
Format	application/pdf
Rights	info:eu-repo/semantics/openAccess